These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9232428)

  • 1. Generation of heat shock protein-based vaccines by intracellular loading of gp96 with antigenic peptides.
    Heikema A; Agsteribbe E; Wilschut J; Huckriede A
    Immunol Lett; 1997 Jun; 57(1-3):69-74. PubMed ID: 9232428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naked RNA immunization with replicons derived from poliovirus and Semliki Forest virus genomes for the generation of a cytotoxic T cell response against the influenza A virus nucleoprotein.
    Vignuzzi M; Gerbaud S; van der Werf S; Escriou N
    J Gen Virol; 2001 Jul; 82(Pt 7):1737-1747. PubMed ID: 11413386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of MHC class I-restricted CTL response by DNA immunization with ubiquitin-influenza virus nucleoprotein fusion antigens.
    Fu TM; Guan L; Friedman A; Ulmer JB; Liu MA; Donnelly JJ
    Vaccine; 1998 Nov; 16(18):1711-7. PubMed ID: 9778746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza basic polymerase 2 peptides are recognized by influenza nucleoprotein-specific cytotoxic T lymphocytes.
    Anderson RW; Bennink JR; Yewdell JW; Maloy WL; Coligan JE
    Mol Immunol; 1992 Sep; 29(9):1089-96. PubMed ID: 1495499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of cytotoxic T lymphocyte activity by immunization with recombinant Semliki Forest virus: indications for cross-priming.
    Huckriede A; Bungener L; Holtrop M; de Vries J; Waarts BL; Daemen T; Wilschut J
    Vaccine; 2004 Mar; 22(9-10):1104-13. PubMed ID: 15003637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenes.
    Ikonomidis G; Paterson Y; Kos FJ; Portnoy DA
    J Exp Med; 1994 Dec; 180(6):2209-18. PubMed ID: 7964496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against lethal viral infection by vaccination with nonimmunodominant peptides.
    Oukka M; Manuguerra JC; Livaditis N; Tourdot S; Riche N; Vergnon I; Cordopatis P; Kosmatopoulos K
    J Immunol; 1996 Oct; 157(7):3039-45. PubMed ID: 8816413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
    Altenburg AF; van de Sandt CE; van Trierum SE; De Gruyter HLM; van Run PRWA; Fouchier RAM; Roose K; Saelens X; Volz A; Sutter G; de Vries RD; Rimmelzwaan GF
    J Virol; 2016 Nov; 90(22):10209-10219. PubMed ID: 27581985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96.
    Ishii T; Udono H; Yamano T; Ohta H; Uenaka A; Ono T; Hizuta A; Tanaka N; Srivastava PK; Nakayama E
    J Immunol; 1999 Feb; 162(3):1303-9. PubMed ID: 9973383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96.
    Arnold D; Faath S; Rammensee H; Schild H
    J Exp Med; 1995 Sep; 182(3):885-9. PubMed ID: 7650492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentation by a major histocompatibility complex class I molecule of nucleoprotein peptide expressed in two different genes of an influenza virus transfectant.
    Isobe H; Moran T; Li S; Young A; Nathenson S; Palese P; Bona C
    J Exp Med; 1995 Jan; 181(1):203-13. PubMed ID: 7528768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
    Brett SJ; Rhodes J; Liew FY; Tite JP
    J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96.
    Qian J; Wang S; Yang J; Xie J; Lin P; Freeman ME; Yi Q
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8808-15. PubMed ID: 16361569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No recognition of MHC class II+ cells infected with a vaccinia virus encoding influenza type A nucleoprotein by class II-restricted T cells.
    Freer G; Senesi S
    Immunol Lett; 1993 Jun; 36(3):305-12. PubMed ID: 8370602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease.
    Anderson LD; Mori S; Mann S; Savary CA; Mullen CA
    Cancer Res; 2000 Oct; 60(20):5797-802. PubMed ID: 11059776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock protein-peptide complexes for use in vaccines.
    Heike M; Noll B; Meyer zum Büschenfelde KH
    J Leukoc Biol; 1996 Aug; 60(2):153-8. PubMed ID: 8773575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of a viral protein by muscle cells in vivo induces protective cell-mediated immunity.
    Ulmer JB; Deck RR; DeWitt CM; Fu TM; Donnelly JJ; Caulfield MJ; Liu MA
    Vaccine; 1997 Jun; 15(8):839-41. PubMed ID: 9234528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells.
    Ulmer JB; Deck RR; Dewitt CM; Donnhly JI; Liu MA
    Immunology; 1996 Sep; 89(1):59-67. PubMed ID: 8911141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.
    Zaghouani H; Kuzu Y; Kuzu H; Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA
    Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma-reactive class I-restricted cytotoxic T cell clones are stimulated by dendritic cells loaded with synthetic peptides, but fail to respond to dendritic cells pulsed with melanoma-derived heat shock proteins in vitro.
    Fleischer K; Schmidt B; Kastenmüller W; Busch DH; Drexler I; Sutter G; Heike M; Peschel C; Bernhard H
    J Immunol; 2004 Jan; 172(1):162-9. PubMed ID: 14688322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.